Depressed mood after intracerebral hemorrhage: the FAST trial

Michael C Christensen1, Stephan A Mayer, Jean-Marc Ferran

  • 1Global Development, Novo Nordisk A/S, Bagsvaerd, Denmark. mcrc@novonordisk.com

Insights

Approximately 20% of intracerebral hemorrhage (ICH) survivors experience depressed mood, negatively impacting their quality of life (QoL). Early identification and treatment of depression are crucial for stroke survivors to improve outcomes.

Area of Science:

  • Neurology
  • Psychiatry
  • Public Health

Background:

  • Depression is a common complication following stroke.
  • Limited data exist on depression prevalence and its impact on quality of life (QoL) in intracerebral hemorrhage (ICH) survivors.

Purpose of the Study:

  • To determine the prevalence of depressed mood 90 days after ICH.
  • To investigate the relationship between depressed mood and QoL in ICH survivors.

Main Methods:

  • Utilized data from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
  • Assessed depressed mood using the Hamilton Depression Rating Scale (HDRS) and QoL with the EuroQoL at 90 days post-ICH.
  • Employed multivariate logistic regression and Spearman correlation to analyze predictors and relationships.

Main Results:

  • 20% of ICH survivors reported depressed mood (HDRS >10) at 90 days.
  • Predictors of depressed mood included comorbidities, neurological impairment (NIHSS), physical disability (Barthel Index), and female gender.
  • Depressed mood severity significantly correlated with poorer QoL, regardless of disability levels.

Conclusions:

  • Depressed mood is prevalent in approximately 20% of ICH survivors and significantly impairs QoL.
  • Healthcare providers should actively monitor and treat depression in ICH survivors, especially those with chronic illness or severe impairment.
Abstract